Literature DB >> 18855315

The role of the pediatric surgeon in the perinatal multidisciplinary team.

E H Raboei1.   

Abstract

BACKGROUND AND AIM: The pediatric surgeons' understanding of the etiology of many prenatally diagnosed surgical conditions has grown significantly in recent years. The impact of prenatal pediatric surgical consultation on the perinatal course has not been explored extensively. The aim of this study was to explore the pediatric surgeon's role as a team member on the management and outcome of prenatally diagnosed surgical congenital anomalies.
MATERIAL AND METHODS: A retrospective study was performed of all pregnant women diagnosed at our institution by antenatal ultrasound as having a fetus with congenital anomalies. The pediatric surgeon's role in decisions on the termination of pregnancy, IN UTERO intervention, or an altered mode or timing of delivery was studied. Patients were divided according to prenatal decisions into 5 groups; group one included those who had nonaggressive obstetric management, groups two and three included pregnancies where the mode or time of delivery was changed, group four consisted of patients who underwent amniocentesis for karyotype analysis and group five had a termination of pregnancy.
RESULTS: There were 406 fetuses diagnosed with congenital anomalies out 20 995 pregnancies. The incidence of congenital anomalies was 1.93 %. The total number of surgical anomaly cases was 234/400 (58.5 %). The pediatric surgeon was the team leader for the management and counseling of parents in 184 out of 227 cases (82.4 %) in group one, two (0.85 %) and 10 (4.3 %) patients in groups 2 and 3, respectively. The pediatric surgeon was the main team member who took the decision in groups 4 and 5. Eighty-three out of 400 cases (35.5 %) had amniocentesis. Although termination of pregnancy in 26/83 (31.3 %) or an altered mode or time of delivery was the outcome for group four; this was not related to the results of the test. Twenty-six pregnancies (11 %) were terminated in group five. The pregnancy terminations included fetuses with Potter's and VATER syndrome, multiple congenital anomalies and conjoined twins.
CONCLUSION: The pediatric surgeon should be a member of the perinatal multidisciplinary team. Prenatal pediatric surgical consultations have a significant impact on the perinatal management of a fetus with congenital anomalies by providing obstetric colleagues and families with valuable information into the surgical management of anomalies.

Entities:  

Mesh:

Year:  2008        PMID: 18855315     DOI: 10.1055/s-2008-1038641

Source DB:  PubMed          Journal:  Eur J Pediatr Surg        ISSN: 0939-7248            Impact factor:   2.191


  5 in total

Review 1.  Team counseling in prenatal evaluation: the partnership of the radiologist and genetic counselor.

Authors:  Margaret B Menzel; Anne K Lawrence; Eva I Rubio; Dorothy I Bulas
Journal:  Pediatr Radiol       Date:  2018-03-17

Review 2.  Antenatally Diagnosed Surgical Conditions: Fetus As Our Patient.

Authors:  Kashish Khanna; Anjan Kumar Dhua; Veereshwar Bhatnagar
Journal:  Indian J Pediatr       Date:  2018-07-03       Impact factor: 1.967

3.  Prenatal counseling for cloaca and cloacal exstrophy-challenges faced by pediatric surgeons.

Authors:  Andrea Bischoff; Maria A Calvo-Garcia; Naira Baregamian; Marc A Levitt; Foong-Yen Lim; Jennifer Hall; Alberto Peña
Journal:  Pediatr Surg Int       Date:  2012-08       Impact factor: 1.827

4.  The Value of Implementing Multidisciplinary Perinatal Care Conference in the Private Practice Setting.

Authors:  Robert C Johnston; Sina Haeri; Richard T Hale; William Lindsley; Annette McCormick; Eric Su
Journal:  AJP Rep       Date:  2017-11-13

5.  Perinatal and follow-up outcome study of fetal anomalies with multidisciplinary consultation.

Authors:  Genxia Li; Na Yang; Mingkun Xie; Yajuan Xu; Ning Han; Qi Chen; Hezhou Li; Yueli Wu; Chunhua Cheng; Yuhong Wang; Man Zhou; Bo Xia; Shuhua Guo; Shihong Cui
Journal:  Ther Clin Risk Manag       Date:  2017-10-04       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.